This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors | MicrobiomeTrials
← Back to trials NCT07567222
Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-06-05Est. Completion: 2026-12-31
Enrollment target: 54 participantsLocations West China Hospital, Sichuan University, Chengdu, Sichuan, China West China Hospital, Sichuan University, Chengdu, Sichuan, China Other microbiome trials you might be interested in EGFR Overexpression Locally Advanced Solid Tumor Metastatic Solid Tumor
This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Ad…
Seoul, South Korea Est. completion Jun 2027
Melanoma Li-Fraumeni Syndrome Pulmonary Blastoma Chordoma Congenital Bone Marrow Failure Syndromes Costello Syndrome Fanconi Anemia
CFC Syndrome (CFCS)
Legius Syndrome
RASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United States Est. completion Jan 1, 2035
Localized Clear Cell Renal Cell Carcinoma Resectable Clear Cell Renal Cell Carcinoma Stage II Renal Cell Cancer AJCC v8 Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8
This phase II trial studies how well ivonescimab works prior to surgery in treating patients with high-risk clear cell k…
Duarte, United States Est. completion Sep 8, 2027